Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies  >  All News

News : Companies

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Research and Markets: Vaccine Market to 2019 - The Market is Expected to Reach $57.8 Billion by 2019 from $33.1 Billion in 2014

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/14/2015 | 04:50pm CET

Research and Markets (http://www.researchandmarkets.com/research/mcbchq/vaccine_market_by) has announced the addition of the "Vaccine Market by Technology, Type, End User, Disease Indication - Forecasts to 2019" report to their offering.

Vaccine Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) - Forecasts to 2019

The vaccines market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%. For the purposes of this report the global vaccines market is categorized on the basis of type, technology, disease indication, end user, and geography. The preventive vaccines segment is expected to register the highest growth rate in the vaccines market, by type, during the forecast period. Its favorable growth is attributed to the rising prevalence of diseases and increasing number of government initiatives taken for immunization programs worldwide.

Major factors contributing to growth of the vaccines market include rising prevalence of diseases, increasing company investments in vaccine development, and rising initiatives by non-government organizations for vaccinations. Furthermore, government support in the form of funding is another major factor providing impetus for growth of this market. For instance, in November 2014, the U.K. government granted $2 billion (£1.32 billion) to GAVI for the improvement of immunization programs in poor countries.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Vaccines Market, By Technology

8 Vaccines Market, By Type

9 Vaccines Market, By Disease Indication

10 Vaccines Market, By End User

11 Global Vaccine Technology Market, By Region

12 Competitive Landscape

13 Company Profiles

14 Appendix

Companies Mentioned

  • Bavarian Nordic
  • CSL Limited
  • Emergent Biosolutions, Inc.
  • Glaxosmithkline, PLC.
  • Johnson & Johnson
  • Medimmune, LLC. (A Subsidiary of Astrazeneca)
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.
  • SANOFI

For more information visit http://www.researchandmarkets.com/research/mcbchq/vaccine_market_by


© Business Wire 2015
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
07:48pAFCON 2019 : Christian Chukwu urges Eagles to begin early preparations
AQ
07:37pMASTERCARD : UK executives from Mastercard, Citi in Israel to scout out partnerships
AQ
07:35pMARCUS HILES : What Amazon’s HQ2 Decision Means for New York’s Long Island Housing Market
GL
07:32pORASCOM INVESTMENT SAE : EFSA receives tender offer from Orascom to purchase Sarwa Capital shares
AQ
07:32pSarwa Capital buys 28.4 million shares at public offering price
AQ
07:25pEXXON MOBIL : Turkey warns ExxonMobil against drilling with Greek Cypriots
AQ
07:24pNETAPP : Earnings Call Transcript
PU
07:22pINFOSYS : Fed up with corruption, Infosys techie decides to contest Telangana polls
AQ
07:15pMAJORITY OF SAUDI EXECUTIVES ANTICIPATE BUSINESSES TO RISE AT LEAST 28% BY 2020 : Study
AQ
07:14pTATA STEEL : Jamshedpur Run-a-thon 2018 captivates the city
PU
Latest news "Companies"
Advertisement